Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Lung Neoplasms 2Esophageal Neoplasms 2Anatomic Stage II Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Malignant Solid Neoplasm 1Lymphoma 1Inflammatory Breast Neoplasms 1Hematologic Neoplasms 1Glioma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Paclitaxel 7Cyclophosphamide 6Doxorubicin 5pembrolizumab 3eribulin 3Trastuzumab 3Taxes 3Specimen Handling 3Carboplatin 3pertuzumab 2Radiotherapy 2Epirubicin 2Docetaxel 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1ruxolitinib 1pegfilgrastim 1onvansertib 1olaparib 1neratinib 1grapiprant 1durvalumab 1cobimetinib 1caficrestat 1atezolizumab 1X-Rays 1Therapeutics 1Tamoxifen 1Surgical Procedures, Operative 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × trastuzumab biosimilar HLX02 × 1 year × Clear all
NCT03101748 2026-02-12

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

M.D. Anderson Cancer Center

Phase 1/2 Terminated
34 enrolled 15 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡